aspirin has been researched along with 4-hydroxy-2-nonenal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bermak, J; Weingarten, P; Zhou, QY | 1 |
Brzozowski, T; Konturek, PCh; Konturek, SJ; KwiecieĊ, S | 1 |
Inaba, T; Katayama, Y; Katsura, K; Saito, M; Sakurazawa, M; Toda, Y | 1 |
Feng, J; Guo, J; Guo, Y; Wang, J | 1 |
4 other study(ies) available for aspirin and 4-hydroxy-2-nonenal
Article | Year |
---|---|
Evidence for non-oxidative dopamine cytotoxicity: potent activation of NF-kappa B and lack of protection by anti-oxidants.
Topics: Acetylcysteine; Aldehydes; Animals; Antioxidants; Aromatic-L-Amino-Acid Decarboxylases; Aspirin; Cell Survival; CHO Cells; Clone Cells; Cricetinae; Dopamine; Glutathione; L-Lactate Dehydrogenase; Levodopa; Lipid Peroxidation; Malondialdehyde; NF-kappa B; Recombinant Proteins | 2001 |
The role of reactive oxygen species in action of nitric oxide-donors on stress-induced gastric mucosal lesions.
Topics: Aldehydes; Animals; Aspirin; Gastric Mucosa; Lipid Peroxidation; Male; Malondialdehyde; Molsidomine; Nitric Oxide Donors; Nitroglycerin; Rats; Rats, Wistar; Reactive Oxygen Species; Regional Blood Flow; S-Nitroso-N-Acetylpenicillamine; Statistics, Nonparametric; Stomach Ulcer; Stress, Psychological; Superoxide Dismutase | 2002 |
The effect of cilostazol and aspirin pre-treatment against subsequent transient focal cerebral ischemia in rat.
Topics: Aldehydes; Animals; Aspirin; bcl-2-Associated X Protein; Brain; Cilostazol; Cyclooxygenase 2; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Tetrazoles | 2014 |
Association of aspirin resistance with 4-hydroxynonenal and its impact on recurrent cerebral infarction in patients with acute cerebral infarction.
Topics: Aged; Aldehydes; Aspirin; Cerebral Infarction; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence | 2020 |